Target intelligence / Profile preview

Epidermal barrier restoration

Molecular classification
Other (not a single molecule, receptor, or protein)
01

Overview

Epidermal barrier restoration does not refer to a specific molecule or receptor. Instead, it describes the process of repairing or enhancing the physical and chemical barriers formed primarily by the stratum corneum—the outermost layer of the epidermis. This complex structure consists mainly of corneocytes embedded in lipid matrices composed of ceramides, fatty acids, and cholesterol. Key proteins such as filaggrin aggregate keratin fibers within cells and are degraded into natural moisturizing factors that help retain moisture. The acid mantle (skin pH) also plays an important role in maintaining enzymatic activity for lipid processing and antimicrobial defense. Disruption of this multi-component system leads to increased water loss from the skin surface (transepidermal water loss), greater vulnerability to allergens/infections, and contributes significantly to diseases like atopic dermatitis. Because "epidermal barrier restoration" refers broadly to improving this multifactorial system rather than modulating one defined protein/receptor/enzyme/transporter/etc., it should not be considered a canonical therapeutic target. In summary: "Epidermal barrier restoration" is not itself a molecular entity but rather an important physiological process involving multiple structural proteins (e.g., filaggrin), lipids (ceramides/fatty acids/cholesterol), enzymes involved in their synthesis/breakdown, acidic pH maintenance mechanisms, immune components, etc.

Other names
Epidermal barrierSkin barrierStratum corneum barrierEpidermal permeability barrier
02

Mechanism of action

Drugs that "restore" the epidermal barrier generally work by supplementing lipids/ceramides or reducing inflammation rather than targeting a specific molecule.

03

Biological functions

Barrier to water loss (prevents transepidermal water loss)Protection against pathogens and allergensMaintenance of skin hydration and pH balanceStructural integrity of the skin surface
04

Disease associations

Atopic dermatitis (barrier dysfunction is a key feature)Ichthyosis vulgaris (linked to filaggrin deficiency)Increased susceptibility to infection and inflammation
05

Safety considerations

No direct safety concerns related to "epidermal barrier restoration" as it is not itself a druggable target.
06

Biomarkers

Barrier function can be assessed by measuring transepidermal water loss (TEWL)Filaggrin levels in some contexts

Beyond the preview

Go deeper on Epidermal barrier restoration.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epidermal barrier restoration.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call